Carlar Blackman

TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects

B. Pasche, C. Langefeld, K. Watabe, 2022, NPJ breast cancer.

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

G. Koch, D. Drossman, W. Whitehead, 2003, Gastroenterology.

A Focus Group Assessment of Patient Perspectives on Irritable Bowel Syndrome and Illness Severity

D. Drossman, Lin Chang, W. F. Norton, 2009, Digestive Diseases and Sciences.